Ligand Pharmaceuticals Inc (NASDAQ:LGND)

113.07
Delayed Data
As of Jan 27
 -0.61 / -0.54%
Today’s Change
102.01
Today|||52-Week Range
219.75
-26.80%
Year-to-Date

Today’s Trading

Previous close113.68
Today’s open117.90
Day’s range112.61 - 116.21
Volume8,592
Average volume (3 months)126,619
Market cap$1.9B
Data as of 3:59pm ET, 01/27/2022

Growth & Valuation

Earnings growth (last year)-100.56%
Earnings growth (this year)+31.65%
Earnings growth (next 5 years)+22.50%
Revenue growth (last year)+54.98%
P/E ratio28.3
Price/Sales8.63
Price/Book2.60

Competitors

----
CORTCorcept Therapeutics...-0.61-3.55%
OPKOPKO Health Inc-0.04-1.37%
TGTXTG Therapeutics Inc-5.65-40.65%
Data as of 4:24pm ET, 01/27/2022

Financials

Next reporting dateFebruary 10, 2022
EPS forecast (this quarter)$1.37
Annual revenue (last year)$186.4M
Annual profit (last year)-$3.0M
Net profit margin-1.60%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts